<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35292552</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>02</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1757-790X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>15</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Mar</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>BMJ case reports</Title>
          <ISOAbbreviation>BMJ Case Rep</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Systemic capillary leak syndrome (SCLS) after receiving BNT162b2 mRNA COVID-19 (Pfizer-BioNTech) vaccine.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">e248927</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1136/bcr-2022-248927</ELocationID>
        <Abstract>
          <AbstractText>Systemic capillary leak syndrome (SCLS), also known as Clarkson's disease, is a rare disorder of unknown aetiology. Since SCLS was first described in 1960, fewer than 500 cases have been reported. SCLS is diagnosed by the classic triad of hypotension, haemoconcentration and hypoalbuminaemia resulting from fluid extravasation. Some reports show that SCLS may sometimes occur as a side effect of adenoviral vector COVID-19 vaccines, although there is only one report (two cases) of SCLS after receiving a messenger RNA vaccine. Survival rates for SCLS are very poor without treatment, so it is crucial for clinicians to recognise this disorder. A middle-aged woman who presented with generalised malaise and anasarca after receiving the BNT162b2 COVID-19 vaccine was diagnosed with SCLS. Treatment with methylprednisolone and intravenous immunoglobulin was commenced and her symptoms resolved. We expect that this case report will add to the existing literature on this rare disorder and the side effects of vaccinations.</AbstractText>
          <CopyrightInformation>© BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Inoue</LastName>
            <ForeName>Masatoshi</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Nephrology, Tajimi Hospital, Tajimi, Japan inoue.masatoshi333@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yasue</LastName>
            <ForeName>Yu</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Nephrology, Tajimi Hospital, Tajimi, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kobayashi</LastName>
            <ForeName>Yoichi</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Nephrology, Tajimi Hospital, Tajimi, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sugiyama</LastName>
            <ForeName>Yutaka</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Nephrology, Tajimi Hospital, Tajimi, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>BMJ Case Rep</MedlineTA>
        <NlmUniqueID>101526291</NlmUniqueID>
        <ISSNLinking>1757-790X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014612">Vaccines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014614">Vaccines, Synthetic</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C000711953">mRNA Vaccine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000087503">mRNA Vaccines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>N38TVC63NU</RegistryNumber>
          <NameOfSubstance UI="D000090982">BNT162 Vaccine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000090982" MajorTopicYN="N">BNT162 Vaccine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019559" MajorTopicYN="Y">Capillary Leak Syndrome</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014612" MajorTopicYN="Y">Vaccines</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014614" MajorTopicYN="N">Vaccines, Synthetic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000087503" MajorTopicYN="N">mRNA Vaccines</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">adult intensive care</Keyword>
        <Keyword MajorTopicYN="N">immunological products and vaccines</Keyword>
        <Keyword MajorTopicYN="N">immunology</Keyword>
        <Keyword MajorTopicYN="N">renal system</Keyword>
      </KeywordList>
      <CoiStatement>Competing interests: None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>16</Day>
          <Hour>5</Hour>
          <Minute>55</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35292552</ArticleId>
        <ArticleId IdType="pmc">PMC8928276</ArticleId>
        <ArticleId IdType="doi">10.1136/bcr-2022-248927</ArticleId>
        <ArticleId IdType="pii">15/3/e248927</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Eo TS, Chun KJ, Hong SJ, et al. . Clinical presentation, management, and prognostic factors of idiopathic systemic capillary leak syndrome: a systematic review. J Allergy Clin Immunol Pract
2018;6:609–18. 10.1016/j.jaip.2017.07.021</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaip.2017.07.021</ArticleId>
            <ArticleId IdType="pubmed">28939140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Druey KM, Parikh SM. Idiopathic systemic capillary leak syndrome (Clarkson disease). J Allergy Clin Immunol
2017;140:663–70. 10.1016/j.jaci.2016.10.042</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaci.2016.10.042</ArticleId>
            <ArticleId IdType="pmc">PMC5481509</ArticleId>
            <ArticleId IdType="pubmed">28012935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pineton de Chambrun M, Luyt C-E, Beloncle F, et al. . The clinical picture of severe systemic Capillary-Leak syndrome episodes requiring ICU admission. Crit Care Med
2017;45:1216–23. 10.1097/CCM.0000000000002496</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/CCM.0000000000002496</ArticleId>
            <ArticleId IdType="pubmed">28622216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Amoura Z, Papo T, Ninet J, et al. . Systemic capillary leak syndrome: report on 13 patients with special focus on course and treatment. Am J Med
1997;103:514–9. 10.1016/s0002-9343(97)00272-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0002-9343(97)00272-6</ArticleId>
            <ArticleId IdType="pubmed">9428835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sousa A, Len O, Escolà-Vergé L, et al. . Influenza A virus infection is associated with systemic capillary leak syndrome: case report and systematic review of the literature. Antivir Ther
2016;21:181–3. 10.3851/IMP2989</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3851/IMP2989</ArticleId>
            <ArticleId IdType="pubmed">26330157</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ebdrup L, Druey K, Mogensen TH. Severe capillary leak syndrome with cardiac arrest triggered by influenza virus infection. BMJ Case Rep
2018;29:bcr 2018226108. 10.1136/bcr-2018-226108</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bcr-2018-226108</ArticleId>
            <ArticleId IdType="pmc">PMC6119378</ArticleId>
            <ArticleId IdType="pubmed">30158273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Druey KM, Greipp PR. Narrative review: the systemic capillary leak syndrome. Ann Intern Med
2010;153:90–8. 10.7326/0003-4819-153-2-201007200-00005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7326/0003-4819-153-2-201007200-00005</ArticleId>
            <ArticleId IdType="pmc">PMC3017349</ArticleId>
            <ArticleId IdType="pubmed">20643990</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beber A, Dellai F, Abdel Jaber M, et al. . Systemic capillary leak syndrome triggered by SARS-CoV2 infection: case report and systematic review. Scand J Rheumatol
2022;51:67–9. 10.1080/03009742.2021.1917145</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/03009742.2021.1917145</ArticleId>
            <ArticleId IdType="pubmed">34169783</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheung PC, Eisch AR, Maleque N, et al. . Fatal exacerbations of systemic capillary leak syndrome complicating coronavirus disease. Emerg Infect Dis
2021;27:2529–34. 10.3201/eid2710.211155</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2710.211155</ArticleId>
            <ArticleId IdType="pmc">PMC8462330</ArticleId>
            <ArticleId IdType="pubmed">34314669</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Almawi WY, Beyhum HN, Rahme AA, et al. . Regulation of cytokine and cytokine receptor expression by glucocorticoids. J Leukoc Biol
1996;60:563–72. 10.1002/jlb.60.5.563</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jlb.60.5.563</ArticleId>
            <ArticleId IdType="pubmed">8929546</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Siddall E, Khatri M, Radhakrishnan J. Capillary leak syndrome: etiologies, pathophysiology, and management. Kidney Int
2017;92:37–46. 10.1016/j.kint.2016.11.029</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.kint.2016.11.029</ArticleId>
            <ArticleId IdType="pubmed">28318633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lambert M, Launay D, Hachulla E, et al. . High-Dose intravenous immunoglobulins dramatically reverse systemic capillary leak syndrome. Crit Care Med
2008;36:2184–7. 10.1097/CCM.0b013e31817d7c71</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/CCM.0b013e31817d7c71</ArticleId>
            <ArticleId IdType="pubmed">18552679</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pineton de Chambrun M, Gousseff M, Mauhin W, et al. . Intravenous immunoglobulins improve survival in monoclonal gammopathy-associated systemic capillary-leak syndrome. Am J Med
2017;130:1219.e19–1219.e27. 10.1016/j.amjmed.2017.05.023</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.amjmed.2017.05.023</ArticleId>
            <ArticleId IdType="pubmed">28602874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>MHRA . Coronavirus vaccine – summary of yellow card reporting, 2021. Available: https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting [Accessed 26 Oct 2021].</Citation>
        </Reference>
        <Reference>
          <Citation>European Medical Agency . COVID-19 vaccine safety update Vaxzevria, 2021. Available: https://www.ema.europa.eu/en/documents/covid-19-vaccine-safety-update [Accessed 26 Oct 2021].</Citation>
        </Reference>
        <Reference>
          <Citation>Matheny M, Maleque N, Channell N, et al. . Severe exacerbations of systemic capillary leak syndrome after COVID-19 vaccination: a case series. Ann Intern Med
2021;174:1476–8. 10.7326/L21-0250</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7326/L21-0250</ArticleId>
            <ArticleId IdType="pmc">PMC8252024</ArticleId>
            <ArticleId IdType="pubmed">34125573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Geerse DA, Meynen FMCJ, Gelens MA, et al. . Systemic capillary leak syndrome after influenza vaccination in a peritoneal dialysis patient. Perit Dial Int
2015;35:772–3. 10.3747/pdi.2014.00194</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3747/pdi.2014.00194</ArticleId>
            <ArticleId IdType="pmc">PMC4690641</ArticleId>
            <ArticleId IdType="pubmed">26703855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Théaudin M, Lozeron P, Lacroix C, et al. . Short and long-term effect of IVIg in demyelinating neuropathy associated with MGUS, experience of a monocentric study. Rev Neurol
2011;167:897–904. 10.1016/j.neurol.2011.04.005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neurol.2011.04.005</ArticleId>
            <ArticleId IdType="pubmed">22023823</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gousseff M, Arnaud L, Lambert M, et al. . The systemic capillary leak syndrome: a case series of 28 patients from a European registry. Ann Intern Med
2011;154:464–71. 10.7326/0003-4819-154-7-201104050-00004</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7326/0003-4819-154-7-201104050-00004</ArticleId>
            <ArticleId IdType="pubmed">21464348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>The Japanese Ministry of Health, Labor and Welfare . Available: https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/vaccine_hukuhannou-utagai-houkoku.html [Accessed 26 Oct 2021].</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
